Some points to consider regarding these discordances in lesion classification include the fact that the uptake of PSMA ligands has been reported in a variety of benign conditions associated with osteoblastic activity, including osteoarthritis, degenerative changes, fibrous dysplasia, consolidation fractures and post radiotherapy (27). This evidence concerns the gene FOLH1 and fibrous dysplasia.